Chemical Engineering in the Pharmaceutical Industry 2010
DOI: 10.1002/9780470882221.ch43
|View full text |Cite
|
Sign up to set email alerts
|

Continuous Processing in Secondary Production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 13 publications
0
6
0
Order By: Relevance
“…In the pharmaceutical industry multipurpose plants are common because they limit capital investment costs, whereas in the bulk chemical industry dedicated continuous plants are generally the solution of choice . The continuous processing strategy allows a just in time (JIT) production approach and has a reduced footprint. , A JIT approach produces less waste and reduces costs because, among others, the product accumulation and storage requirements are significantly less. A dedicated continuous plant, commonly used in other industries, is only feasible when large amounts of API are required (∼100 T/year), because of the logistics to put it in place.…”
Section: Impact In Larger Batches For Initial Clinical Studies and Pr...mentioning
confidence: 99%
“…In the pharmaceutical industry multipurpose plants are common because they limit capital investment costs, whereas in the bulk chemical industry dedicated continuous plants are generally the solution of choice . The continuous processing strategy allows a just in time (JIT) production approach and has a reduced footprint. , A JIT approach produces less waste and reduces costs because, among others, the product accumulation and storage requirements are significantly less. A dedicated continuous plant, commonly used in other industries, is only feasible when large amounts of API are required (∼100 T/year), because of the logistics to put it in place.…”
Section: Impact In Larger Batches For Initial Clinical Studies and Pr...mentioning
confidence: 99%
“…37 CM is a culmination of all of the unit operations, working in tandem, converting raw-material input into final product in one continuous operation. 9 A number of academic research groups, including the GEA-NUS Pharmaceutical Research Laboratory, Singapore, headed by Professor Paul Heng, the CSOPS group at Rutgers University, headed by Professor Fernando Muzzio, and the Novartis MIT Center for Continuous Manufacturing, to name a few, are all leading the way in the application of PAT tools for monitoring and controlling CM processes. Figure 5 provides a schematic view of a typical CM operation for solid dose manufacturing.…”
Section: Role Of Nir Spectroscopy In CMmentioning
confidence: 99%
“…Since all unit operations are connected to each other in CM, the reliance on PAT tools to predict product quality is essential. NIR spectroscopy in particular finds use in the following: 9 n Raw material dispensing: Continuous monitoring of the raw-material components can provide information to downstream unit operations on how to process the materials based on their characteristics. It also provides a continuous verification mechanism (i.e.…”
Section: Role Of Nir Spectroscopy In CMmentioning
confidence: 99%
See 1 more Smart Citation
“…While NIR spectroscopy may find niche applications in clinical trial studies, its focus is more on developing process monitoring and control strategies that allow the process to adapt to any changes to the materials induced by the process or the natural variability of the raw materials. This has culminated in approaches such as continuous manufacturing, 10 which has a great reliance on PAT tools such as NIR spectroscopy to make quality decisions in real time in order to pass material seamlessly from one unit operation to the next. A continuous manufacturing process is by definition a QbD process, in which PAT tools such as NIR spectroscopy play prominent roles.…”
Section: Brad Swarbrickmentioning
confidence: 99%